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ABSTRACT 
Objective: To determine if time to disposition decisions for emergency department(ED) 
patients can be reduced when blood tests are processed using point-of-care(POC) devices; to 
conduct a cost-effectiveness analysis of POC compared to laboratory testing.  
Methods: This randomised trial enrolled adults suspected of an acute coronary 
syndrome(ACS) or presenting with conditions considered to only require blood tests 
available by POC. Participants were randomised to have blood tests processed by POC or 
laboratory. Outcomes measured were time to disposition decision and ED length-of-
stay(LOS). The cost-effectiveness analysis calculated total and mean costs per ED 
presentation, as well as total and mean benefits in time saved to disposition decision. 
Results: There were 410 POC participants and 401 controls. The mean times to a disposition 
decision for POC versus controls was 3.24 hours and 3.50 hours respectively, a difference of 
7.6%(95%CI 0.4%–14.3%, p=0.04) and 4.32 and 4.52 hours respectively for EDLOS, a 
difference of 4.4%(95%CI -2.7%–11.0%, p=0.21). Improved processing time was greatest for 
participants enrolled by senior staff with a reduction in time to disposition decision of 
19.1%(95%CI 7.3%–29.4%, p<0.01) and EDLOS of 15.6%(95%CI 4.9%–25.2%, p=0.01). 
Mean pathology costs were $12 higher in the POC group (95%CI $7-18) and the incremental 
cost-effectiveness ratio was $113 per hour saved in time to disposition decision for POC 
compared to standard laboratory testing. 
Conclusions: Small improvements in disposition decision time were achieved with POC 
testing, for a moderate increase in cost. Greatest benefit may be achieved when POC is 
targeted to senior medical staff.  
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INTRODUCTION 
Reducing the time that patients stay in the Emergency Department (ED) is a desirable goal to 
reduce over-crowding, improve patient flow, improve patient satisfaction and reduce 
morbidity and mortality.
1-5
 Australian EDs also must comply with the recently introduced 
National Emergency Access Target of 4 hours for completion of ED management.
6
 Point-of-
care(POC) testing, defined as laboratory testing in or near a patient location with rapid 
availability of test results, has the potential to reduce ED length-of-stay(LOS) through short 
turn-around times allowing clinical decisions to be made earlier.  
The literature has conflicting results and it is not clear if POC testing can achieve the benefits 
of faster decision making and shorter ED LOS. A before/after study design
7
 using POC 
troponin testing for acute coronary syndromes(ACS) demonstrated shorter ED LOS and time 
to admission decisions, a quasi-randomised trial
8
 was only able to demonstrate a trend to 
shorter ED LOS, while two randomised trials failed to demonstrate a benefit.
9-10
 In studies of 
POC testing using machines that perform a variety of blood tests, two before/after studies 
demonstrated shorter ED LOS
11-12
 while a third did not,
13
 a small randomised trial found a 
shorter ED LOS,
14
 but a large randomised trial was unable to demonstrate a difference in ED 
LOS, hospital LOS, admission rates or mortality.
15
 None of these studies have assessed cost-
effectiveness of POC devices in the ED. 
In this study we tested the hypothesis that the short turn-around times of POC devices would 
translate to improved patient processing times. The primary aim of this study was to 
determine if the time to make an admission or discharge decision (hereafter referred to as a 
disposition decision) could be reduced with common blood tests being available by POC 
testing in the ED. Secondary aims were to investigate improvements in processing times on 
several patient subgroups, and to perform a cost-effectiveness analysis of POC compared to 
central laboratory testing from an Australian health system perspective. 
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METHODS 
Study design and Setting 
This study was an open, parallel arm, randomised trial conducted in the ED of a tertiary 
referral and level 1 trauma centre located in Sydney, New South Wales, Australia, over a six 
month period from December 2011 to May 2012. The ED has approximately 65,000 
presentations a year, and pathology services are available 24 hours a day. Permission for the 
study was granted by the South Eastern Sydney and Illawarra Area Health Service (central 
network) Human Research Ethics Committee and registered with the Australia and New 
Zealand Clinical Trials Registry (ANZCTR #12611001228976). Funding for this study was 
provided by a grant from the NSW Department of Health (Ministerial Taskforce on 
Emergency Care “Taking the pressure of public hospitals” project grants 2011/12) and from 
the study hospital.  
Selection of participants 
Patients presenting to the ED were eligible for the study if they were ≥18 years of age, and 
fulfilled the requirements for either of the following two groups. The first group (ACS group) 
were patients suspected of having an ACS. Those with acute ST-elevation myocardial 
infarction were excluded. The second group (general group) were patients whom the 
enrolling staff member thought would only need blood tests from the selection available by 
POC to complete assessment and management. The POC blood tests available were 
creatinine, electrolytes, glucose, calcium, haemoglobin, Troponin T, D-Dimer, beta-HCG, 
and INR. The POC devices used were the Radiometer ABL-800 FLEX blood-gas analyser, 
Radiometer AQT-90 FLEX, and the Roche CoaguChek XS-PRO. Patients who presented 
more than once to the ED within the study period could be re-enrolled. 
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Participants were enrolled by nurses, nurse-practitioners and doctors from intern to consultant 
level. Nurses could enrol participants as it is routine practice in this ED for nurses to ‘fast-
track’ blood tests for patients waiting to be seen by a doctor. Study recruitment was driven by 
regular education and updates at staff meetings, and regular encouragement by the research 
staff in the department. 
Method of randomisation 
The requirement for obtaining individual patient consent was waived by the ethics 
committee. Participants meeting the inclusion/exclusion criteria were randomly allocated by 
opening sequentially numbered, sealed, opaque envelopes which contained the study 
allocation. Randomisation was stratified according to clinical group (ACS or general). To 
ensure balanced numbers of participants in each arm of the study block randomisation was 
used, with blocks of variable size to prevent prediction of the allocation sequence in this non-
blinded study. The randomisation sequence was created using a computerised random 
number generator. 
Interventions 
For participants allocated to the intervention, in the general group all blood tests were 
processed in the ED using the POC devices. For participants in the ACS group, only the 
troponin was processed using the POC device, and other blood tests if required were sent to 
the central laboratory for processing. This was because we considered troponin to be the 
critical blood test for making a disposition decision in patients with an ACS, while other tests 
often are requested for ‘baseline’ measurement and infrequently influence management and 
disposition. Turn-around times for the POC devices (time from specimen insertion into the 
POC device to availability of the result) ranged from 2 minutes to 22 minutes.  
For participants allocated to the control arm of the study (ACS and general groups) all blood 
tests were sent to the central hospital pathology service for processing. Turn-around times for 
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laboratory tests (time from sending a specimen to the laboratory to availability of the result) 
usually take between 30 minutes and 2 hours.  
Following this initial set of testing any additional pathology required was performed in the 
central laboratory. 
Outcome measures 
The primary outcome was the time from ED arrival to disposition decision. This was chosen 
as the primary outcome (rather than ED LOS) as delays in accessing in-patient ward beds and 
ultimate transfer out of ED may mask a benefit in patient processing time. 
The secondary outcomes were ED LOS for the whole study population; time to disposition 
decision and ED LOS for the following subgroups: diagnostic group (ACS or general), 
disposition (discharged home, admitted to the ward, admitted to the Emergency Medicine 
Unit which is an ED short stay ward), seniority of enrolling staff. A cost-effectiveness 
analysis of POC testing compared to central laboratory testing was conducted.  
All outcomes measured were pre-specified with the exception of seniority of enrolling staff 
which was the only exploratory subgroup analysis performed. 
Methods and Measurements 
The staff member enrolling a participant entered diagnostic information on a data collection 
form. For those in the general group this was the provisional diagnosis, while those in the 
ACS group were stratified to a low, intermediate or high risk category. Demographic data and 
times for the primary and secondary outcomes were obtained from the ED computer 
management system in which the times of all significant events in the patient journey are 
entered. The time of admission decision was defined as the time that the clinician notified the 
nurse in charge to book a bed following patient acceptance by an admitting team. For patients 
sent home, the discharge decision time was the departure ready time as entered by the 
8 
 
clinician into the ED computer management system. This was often the same as the departure 
time but may be earlier for patients awaiting transportation home.  
Analysis 
The required sample size was determined using the mean and standard deviation of the 
disposition decision time for the study population estimated from a pilot study conducted 
over 2 months prior to the start of the randomised trial. Clinicians completed a survey for 
each adult patient seen to identify patients fulfilling inclusion/exclusion criteria. Disposition 
decision times were obtained from the ED computer management system. We considered a 
15% reduction in disposition decision time to be the minimum clinically important reduction. 
Using a power of 80% and an α-level of 0.05, 450 participants were needed. We required this 
study to be powered for subgroup analysis, in particular the ACS group. The pilot study 
demonstrated the ACS group and the whole study group to have a similar mean and standard 
deviation, so we determined to stop the study once 450 participants had been enrolled in the 
ACS group. 
The primary analysis was by intention-to-treat. The outcome measures of time to disposition 
decision and ED LOS were positively skewed. Therefore, the data were first transformed to a 
normal distribution by taking the natural logarithm and the analysis was conducted by 
comparing the means of the natural logarithm of these outcomes using linear regression. The 
differences in time between study groups are presented as percentage reductions in the means 
of the logarithmically transformed data, while the average times presented are the geometric 
means, which are the means of the logarithmically transformed data back-transformed using 
the exponential. A random effect model was included to adjust for repeated presentations 
over the period of the study. This analysis was conducted in Stata 12(StataCorp LP, Texas, 
USA). 
Economic evaluation 
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The cost-effectiveness analysis calculated total and mean costs per ED presentation, as well 
as total and mean benefits in time saved to disposition decision. All pathology and radiology 
tests from the time of arrival to the time of disposition decision were obtained from the 
pathology and radiology databases respectively. Direct unit costs from the pathology service 
provider and hospital casemix data were obtained for each pathology and radiology 
diagnostic test. Indirect costs for capital equipment (i.e. POC analysers) were calculated 
using the equivalent annual cost method.
16
 A weighted average clinical staff time for POC 
and laboratory test processing was derived from a time-in-motion study with 25 consecutive 
ED presentations. The differences between costs in the two groups, and the 95% confidence 
intervals were then calculated. Volumes of resources and costs are reported as mean values 
with standard deviations and as mean differences with 95% confidence intervals. Discounting 
was not applied. The arithmetic mean of the disposition decision time (rather than the 
geometric mean as described above) was used in the calculation of an incremental cost-
effectiveness ratio (ICER) for POC compared to central laboratory testing, as this is the 
standard methodology used for economic evaluations. The ICER was calculated using the 
following formula: (mean cost of POC – mean cost of control)/(mean effect of POC – mean 
effect of control). Non-parametric bootstrapping was employed for a 95% confidence interval 
around the ICER. The economic analysis was conducted in Excel 2007(Microsoft, USA). 
 
RESULTS 
Characteristics of study subjects 
There were 881 presentations enrolled. Sixty six enrolment forms were not returned 
preventing identification of the participant. Two participants were excluded as they were 
enrolled in both arms of the study for the same presentation. This left 811 presentations 
available for the intention-to-treat analysis. There were 410 presentations randomised to POC 
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and 401 to the control arm of the study (Figure 1). Nineteen participants presented and were 
enrolled more than once during the study: 17 participants had two observations, one 
participant had three observations, and one participant had five observations. The trial was 
balanced with respect to baseline characteristics (Table 1).  
Main results 
For the primary outcome, POC testing reduced the time to a disposition decision from a mean 
of 3.50 hours to 3.24 hours, a difference of 0.26 hours or 7.6% (95%CI 0.4%–14.3%, 
p=0.04), with trends toward shorter decision making times in all subgroups analysed (table 
2). There was a reduction in ED LOS of 4.4%, from 4.52 to 4.32 hours. This difference was 
not statistically significant (95%CI -2.7%–11.0%, p=0.21). There were trends toward shorter 
ED LOS in all but one of the subgroups analysed (Table 3). The improvement in patient 
processing times were greatest for those patients enrolled by senior staff (consultants and 
registrars), with a reduction in the time to a disposition decision of 19.1% (95%CI 7.3%–
29.4%, p<0.01) and ED LOS of 15.6% (95%CI 4.9%–25.2%, p=0.01). Testing for interaction 
was performed to determine if there was evidence that the effect of the intervention on 
processing time depended on the seniority of the enrolling staff (test for interaction p=0.06 
and p=0.21 for disposition decision time and ED LOS respectively).   
Economic outcomes 
The calculation of the ICER was based on the arithmetic mean time to a disposition decision 
(rather than the geometric mean presented in the main results). This was 3.78 hours in the 
POC group and 3.99 hours for the control group, a difference of 0.21 hours (13 minutes) in 
favour of POC testing.  
Resource utilisation 
Table 4 shows the utilisation of health-care resources per ED presentation according to the 
study group allocation. The number of pathology, radiology and cardiology tests per 
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presentation did not significantly differ between the groups. The ED staff time for hands-on 
pathology processing was significantly shorter in the POC group compared to the control 
group (1.34 minutes, 95%CI 1.22–1.46).   
Health-care costs 
Health-care costs per ED presentation are also reported in Table 4.  For pathology costs, there 
was no significant difference in the mean volume of tests; however the mean cost per patient 
was $12 higher in the POC group, (95% CI $7-$18). The overall health-care costs per ED 
presentation were $174+/-$157 in the POC group and $150+/-$129 in the control group, a net 
difference of $24 (95%CI $4–$44) in favour of the control group.  
Cost-effectiveness 
The point estimate of the incremental cost-effectiveness ratio (ICER) was $113 per hour 
saved in time to a disposition decision for POC compared to standard laboratory testing. 
Figure 2 shows a cost-effectiveness plane with a plot of the bootstrap replicates of per-
presentation incremental costs and incremental hours saved. Seventy percent of replicates 
were in the north-east quadrant of the plane, showing that in the majority of cases POC had 
both higher costs and higher effects (i.e saved time) compared to the control group.  
Figure 3 shows a cost-effectiveness acceptability curve of POC testing at different 
willingness to pay levels for one hour of time saved to disposition decision. This curve 
indicates the probability that an intervention is cost-effective compared to its alternative, 
given the data, for a range of values up to a maximum acceptable ceiling ratio. If the 
Australian health system were willing to pay $120  or higher in order to save one hour of time 
in the ED then our data suggests POC testing has an 80% probability of being cost-effective. 
 
DISCUSSION 
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In this randomised trial we were able to demonstrate a small reduction in the time to reach a 
disposition decision and in the ED LOS amongst participants randomised to POC testing. 
While the improvement in the primary outcome was statistically significant, we had pre-
specified that we considered the minimum clinically important reduction to be 15%. In the 
subgroup analysis, there were trends toward small improvements in processing times with the 
exception of participants enrolled by senior staff where the outcomes were considerably 
better and exceeded our minimum clinically important reduction. 
There are a number of reasons why only modest improvements were demonstrated. 
Physicians seeing several patients simultaneously may have got caught up in clinical care 
delaying action on an available result. Participants enrolled by nurses were having tests ‘fast-
tracked’ prior to being seen by a doctor, so the benefit of POC testing may have been 
nullified by prolonged waiting times. Possibly the most important factor was that a junior 
doctor’s ability to make decisions could be influenced more by the time taken to obtain a 
history, examination and consultation with a senior rather than the turn-around time of a test. 
As the majority of patients were enrolled by junior doctors this would have had a strong 
influence towards a null effect. This is supported by the subgroup analysis of processing 
times according to the seniority of the clinician. Contrary to what would be expected, 
processing of POC specimens did not add an extra time burden to ED staff as demonstrated 
by the time-in-motion studies. The reason for this is that specimens for the central laboratory 
required a computer generated request form, with time consumed through logging on, 
entering required tests, electronic signatures and printing. 
These are important findings for departments considering the implementation of POC 
devices, particularly for tertiary EDs with large numbers of junior staff, and laboratory 
services available 24 hours a day. Our results would indicate that in such a setting only small 
benefits could be expected. However, if the use was targeted to senior staff with the 
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experience and ability to make rapid decisions, clinically relevant benefits can be realised. It 
is also important to emphasise the importance of system improvements to ensure flow of 
patients out of the ED as any improvements in efficiency within the ED will be quickly lost, 
an effect echoed in our results with smaller improvements seen in ED LOS compared to a 
disposition decision.  
Despite these modest improvements in processing time, the increased cost of POC testing to 
the Australian health care system is relatively small for the benefit of an hour saved in 
disposition decisions. To put our price of $113 into perspective, Australian EDs are funded 
based on their activity, with this ED allocated $505 per patient treated.
17
 Participants enrolled 
in this study had an average LOS of approximately 4.5 hours. At face value this would equate 
to $112 per patient per hour of their stay, which would suggest that POC testing is a cost 
neutral intervention if time saved in decision making translated to time saved in the ED. 
Previous research in this area has had mixed results, although if only randomised studies are 
considered all but one has failed to demonstrate a benefit from POC devices.
9-10, 14-15
 In 
contrast, this study has demonstrated small benefits and importantly has identified a niche 
amongst senior clinicians for the rational use of POC devices. As far as we are aware our 
study is the first to evaluate the cost-effectiveness of POC devices in the ED. 
Limitations 
This study was not blinded. This study was assessing patient processing times and as POC 
testing involves the ED staff in sample processing it is important that all normal procedures 
that would occur with usual use of POC devices be preserved. As such it was not possible to 
blind staff to the study allocation. Staff behaviour may, however, be influenced by the 
knowledge of study allocation which could introduce systematic bias.  
Another potential source of bias was the loss of 7% of enrolment forms, without which the 
participant that was enrolled could not be identified. If this was a random event this would be 
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unlikely to introduce bias, but if there was a systematic reason such as staff discarding the 
form if they received a particular allocation, this could introduce important bias. Given the 
similar proportion of missing forms in each arm of the study and the balance in baseline 
characteristics, this is likely to have been a random event.  
There may also be inaccuracies in the measurement of the processing times as this relied on 
staff entering the time on the computer management system. When staff were diverted by 
more urgent priorities the time recorded may have been longer. 
The generalisability of results from single centre study is always a concern as the patients or 
conditions unique to a particular institution may reduce the relevance when extrapolated to 
other sites. However, the patient population targeted by this study tended to be of lower 
acuity, with single system problems commonly seen in all EDs, and so our results should be 
relevant to a broad range of ED environments. 
With regards to the economic evaluation, the cost-effectiveness results may be limited in their 
generalisability to tertiary EDs supported by pathology services with similar costs. 
Conclusion 
To conclude, small improvements in time to a disposition decision were achieved with the 
use of POC testing in the ED. Despite the modest benefits, POC testing devices within the 
ED may be a cost effective intervention. The greatest benefit from POC testing may be 
achieved when the use of POC devices is targeted to senior medical staff.  
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Table 1: Baseline characteristics by randomization group 
 
Characteristic 
Control (n=401) POC (n=410) 
Mean or n (SD or %) Mean or n (SD or %) 
Age 57.8 
 
(20.4) 57.7 
 
(20.1) 
     
Sex     
Female 223  (56) 219  (55) 
Male 178  (44) 191  (46) 
     
Arrival mode     
Private Car 247  (62) 264  (63) 
Ambulance 152  (38) 144  (37) 
Police 2  (1) 2  (<1) 
     
Enrolling Staff     
Consultant 36  (9) 48  (10) 
Registrar 77  (19) 83  (20) 
Medical Officer (Junior, Career, Senior Resident) 205  (51) 194  (49) 
Nurse (Registered or Practitioner) 83  (21) 85  (21) 
     
Australasia Triage scale     
1 1  (<1) 1  (<1) 
2 207  (52) 215  (52) 
3 127  (32) 103  (28) 
4 63  (16) 83  (18) 
5 3  (1) 8  (1) 
     
Insurance     
Yes 157  (39) 157  (39) 
No 238  (59) 252  (60) 
Missing 6  (2) 1  (1) 
     
Diagnosis category     
ACS group 233  (58) 235  (58) 
Low risk 77  (19) 65  (18) 
Intermediate risk 103  (26) 119  (27) 
High risk 33  (8) 41  (9) 
ACS risk stratification not specified 20  (5) 10  (4) 
General group 168  (42) 175  (42) 
Non-cardiac chest pain 19  (5) 21  (5) 
Bleeding (nose/GI/respiratory/urine/wound) 18  (4) 16  (4) 
PV bleeding in pregnancy 25  (6) 28  (7) 
Trauma/falls/head injury 15  (4) 12  (3) 
Syncope/vertigo/dizziness 13  (3) 17  (4) 
Palpitations/arrhythmia 11  (3) 7  (2) 
Abdominal /flank pain 10  (2) 15  (3) 
Gastroenteritis/dehydration 9  (2) 7  (2) 
Vomiting 8  (2) 11  (2) 
Anaemia 3  (1) 9  (1) 
Other 37  (9) 32  (9) 
     
Laboratory troponin in ACS subgroup (n = 458†)     
≤ 14ng/L* 171 (75) 175 (76) 
> 14ng/L 58 (25) 54 (24) 
 
    
† Ten presentations had missing laboratory troponin; * Reference range for a negative troponin is ≤ 14ng/L  
Table 2: Time from arrival to disposition decision 
17 
 
        Geometric mean (hours)  
% reduction 
(95% CI) 
 
P-value Control POC 
Overall 3.50 3.24 7.6 (   0.4, 14.3) 0.04 
      
Diagnostic group     0.86
† 
ACS 3.43 3.15 8.2 (  -0.9, 16.5) 0.08 
General 3.61 3.36 6.9 (  -5.2, 17.6) 0.25 
      
Disposition     0.60
† 
Discharge home 3.68 3.50 4.9 (  -5.9, 14.5) 0.36 
Admit to ward 3.66 3.22 12.1 (  -0.8, 23.3) 0.06 
Admit to EMU 2.94 2.81 4.4 (-11.1, 17.8) 0.56 
      
Enrolling staff     0.06
† 
Consultant or registrar 3.63 2.94 19.1 (   7.3, 29.4) <0.01 
Junior medical officer  3.54 3.51 0.9 (  -9.6, 10.4) 0.85 
Nurse 3.24 3.12 3.8 (-15.7, 20.1) 0.68 
† testing for an interaction between treatment and subgroup  
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Table 3: Length of Stay in the Emergency Department  
     Geometric mean (hours)  
% reduction 
(95% CI) 
 
P-value Control POC 
Overall 4.52 4.32 4.4 ( -2.7, 11.0) 0.21 
      
Diagnostic category     0.70
† 
ACS 4.65 4.50 3.1 ( -5.5, 10.9) 0.47 
General 4.34 4.09 5.7 ( -6.6, 16.6) 0.35 
      
Disposition     0.62
† 
Discharge 4.15 3.78 8.9 ( -0.9,  17.7) 0.08 
Admit to ward 5.86 5.52 5.8 ( -5.6,  16.0) 0.31 
Admit to EMU 3.59 3.49 2.8 (-11.2, 15.1) 0.68 
      
Enrolling staff     0.21
† 
Consultant or registrar 4.96 4.19 15.6 (  4.9,  25.2) 0.01 
Junior medical officer  4.51 4.59 -1.7 (-12.4,   7.9) 0.74 
Nurse 4.31 3.70 14.1 ( -1.6,  27.5) 0.08 
 † testing for an interaction between treatment and subgroup  
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Table 4. Mean use of health-care resources and mean total health-care costs per presentation for time to decision according to random allocation 
       
Item POC (n=410)  Control (n=401) Difference 
    Mean (SD)    Mean (SD) Mean   (95%CI) 
 
Volume Cost ($) Volume Cost ($) Volume  Cost ($) 
Pathology tests 4.41 (2.59) 84 (35) 4.38 (2.08) 72 (41) 0.03 (-0.30, 0.36) 12 (7, 18) 
Radiology tests 0.76 (0.71) 85 (145) 0.77 (0.59) 75  (119) -0.01 (-0.10, 0.08) 10 (-8, 28) 
Cardiology tests 0.02 (0.13) 4 (32) 0.01 (0.09) 1 (17) 0.01 (-0.01, 0.03) 3 (-1, 7) 
ED staff time pathology (mins)  1.28 (0.78) 1 (0.1) 2.63 (0.92) 2 (0.1) -1.34 (-1.46, -1.22) -1 (-1, -1) 
Total cost   174 (157)   150 (129)   24 (4, 44) 
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Figure 2: Cost-effectiveness plane showing 1000 bootstrap replicates of incremental cost per hour  
saved (time to disposition decision) for POC vs central laboratory testing 
  
NE= north-east quadrant where interventions are more expensive, but more effective. SE= south-east quadrant where interventions 
are less expensive and more effective. SW= south west quadrant where interventions are less expensive but less effective. NW= 
north-west quadrant where interventions are more expensive and less effective.  
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Figure 3: Cost effectiveness acceptability curve for POC at different willingness to pay levels 
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